 | ADC Therapeutics SA | |||
| NYQ : ADCT || Location: Switzerland | ||||
$4.44-0.34 (-7.11%) |
0.3 M | 4.41 - 4.65 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.888 M |
| March 28, 2024 | 0.993 M |
| March 15, 2024 | 0.940 M |
| Feb. 29, 2024 | 0.869 M |
| Feb. 15, 2024 | 1.430 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.51 | -1.03 | -100.74% |
| 09/30/2023 | -0.65 | -0.58 | 10.34% |
| 06/30/2023 | -0.47 | -0.58 | -24.38% |
| 03/31/2023 | -0.68 | -0.74 | -8.28% |
| 12/31/2022 | -0.29 | -0.30 | -2.56% |
ADCT Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 82.530M | Shares Float | 62.974M |
| Short Float | 0.888M | Market Cap | 366.43M |
| Institution ownership | 41.17% | Insider ownership | 29.003% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.94 | Forward EPS | -1.78 |